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Abstract
Background
Dengue fever is a ubiquitous arboviral infection in tropical and sub-tropical regions, whose
incidence has increased over recent decades. In the absence of a rapid point of care test,
the clinical diagnosis of dengue is complex. TheWorld Health Organisation has outlined
diagnostic criteria for making the diagnosis of dengue infection, which includes the use of
the tourniquet test (TT).
Purpose
To assess the quality of the evidence supporting the use of the TT and perform a diagnostic
accuracy meta-analysis comparing the TT to antibody response measured by ELISA.
Data Sources
A comprehensive literature search was conducted in the following databases to April, 2016:
MEDLINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials, BIOSIS,
Web of Science, SCOPUS.
Study Selection
Studies comparing the diagnostic accuracy of the tourniquet test with ELISA for the diagno-
sis of dengue were included.
Data Extraction
Two independent authors extracted data using a standardized form.
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Data Synthesis
A total of 16 studies with 28,739 participants were included in the meta-analysis. Pooled
sensitivity for dengue diagnosis by TT was 58% (95% Confidence Interval (CI), 43%-71%)
and the specificity was 71% (95% CI, 60%-80%). In the subgroup analysis sensitivity for
non-severe dengue diagnosis was 55% (95% CI, 52%-59%) and the specificity was 63%
(95% CI, 60%-66%), whilst sensitivity for dengue hemorrhagic fever diagnosis was 62%
(95% CI, 53%-71%) and the specificity was 60% (95% CI, 48%-70%). Receiver-operator
characteristics demonstrated a test accuracy (AUC) of 0.70 (95% CI, 0.66–0.74).
Conclusion
The tourniquet test is widely used in resource poor settings despite currently available evi-
dence demonstrating only a marginal benefit in making a diagnosis of dengue infection
alone.
Registration
The protocol for this systematic review was registered at PROSPERO: CRD42015020323.
Author Summary
Dengue is an infectious disease transmitted by mosquitoes in the Tropics. There are 2.5
billion people around the world at risk. Dengue presents as an acute febrile illness with
symptoms including headache, bone or joint and muscular pains and rash. The objective
of this study is to perform a diagnostic accuracy meta-analysis comparing the use of the
Tourniquet Test (TT) to a laboratory assay standard (ELISA) for making a diagnosis of
dengue infection. A comprehensive literature search (to April, 2016) was conducted to
map and assess the quality of the available evidence, using the following databases: MED-
LINE (PubMed), EMBASE, Cochrane Central Register of Controlled Trials, BIOSIS, Web
of Science, SCOPUS. We included 16 studies with 28,739 participants in the meta-analysis.
Pooled sensitivity for dengue diagnosis by TT was 58% (95% Confidence Interval (CI),
43%-71%) and the specificity was 71% (95% CI, 60%-80%). In the pooled subgroup analy-
sis sensitivity for dengue fever diagnosis was 55% (95% CI, 52%-59%) and the specificity
was 63% (95% CI, 60%-66%). The tourniquet test is widely used in resource poor settings
despite currently available evidence demonstrating only a marginal benefit in making a
diagnosis of dengue infection alone.
Introduction
Dengue is an arboviral infection ubiquitous to tropical and sub-tropical regions,[1–3] where it
is transmitted by domesticated day-biting mosquitoes including Aedes aegypti. After an incu-
bation period of 4–10 days (mean, 7 days), illness onset is abrupt (with headache, fever, myal-
gia/arthralgia and rash) and can last up to 14 days[4–8]. Four virus serotypes are in circulation
around the world (DEN-1, DEN-2, DEN-3, DEN-4)[9,10], with specific “Asian” genotypes
within serotypes DEN-2 and DEN-3 being associated with severe dengue infection particularly
in secondary infections [11,12]. According to WHO estimates 50–100 million new dengue
infections occur annually, resulting in 500,000 cases of DHF and 22,000 deaths[11,12]. It is
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thought that approximately 2.5 billion people, or 40% of the world’s population are at risk of
dengue infection, with important factors including warm and humid climate, overcrowding
and residence in major urban centers[11–14].
Virus transmission can cause a spectrum of illness from subclinical to severe dengue infec-
tion characterized by plasma leakage, haemorrhage and end-organ impairment. Characterisa-
tion of specific phenotypes of infection is complex and has recently changed[11–14]. Clinically,
dengue fever presents as an acute febrile disease with symptoms of headache, bone or joint and
muscular pains, rash and leukopenia. Traditionally a further two stages were described, consist-
ing of dengue haemorrhagic fever (DHF), characterized by high fever, haemorrhagic phenom-
ena, often with hepatomegaly. In severe cases, further signs of circulatory failure may develop
culminating in dengue shock syndrome (DSS), which is associated with poor outcomes. More
recent consensus guidance[12] recommends distinction of dengue illness into dengue (with or
without warning signs which may precede the development of more severe infection) and
severe dengue (encompassing the manifestations of severe plasma leakage, severe bleeding or
severe end-organ involvement)[11,12].
The clinical diagnosis of dengue is challenging as the symptoms are non-specific and com-
mon to many other infections[10–12], notably malaria and other arboviral infections. To aid
diagnosis, specifically during the initial, acute, febrile phase which may last 2–7 days after the
development of fever, theWHO recommend the use of the Tourniquet Test (TT, also known as
the Rumpel-Leede or Hess test) to support diagnostic decision-making [13,15–21]. As an inex-
pensive, quick and easy to perform procedure, use of the TT has become widespread in clinical
practice globally. The TT is a marker of capillary fragility and can be undertaken by inflating a
blood pressure cuff around the upper arm to the point midway between the individual’s systolic
and diastolic blood pressures and leaving it inflated for 5 minutes. The cuff is subsequently
released and after two minutes the number of petechiae below antecubital fossa are counted. The
test is positive if more than 10 petechiae are present within a square inch of skin on the arm
[11,12]. The clinical diagnosis of dengue may be confirmed by laboratory testing, which in many
settings involves the measurement of an antibody response (IgM or IgG) by ELISA[3], for years
considered to be the diagnostic standard[22]. This test is less sensitive in the first 5 days after
exposure and frequently relies on testing of paired sera samples. Newer tests available in some
centres include reverse-transcriptase PCR (polymerase chain reaction) or direct antigen detec-
tion (non-structural protein 1). While these tests are likely to offer an improvement in diagnostic
accuracy, the cost and current limitation of not detecting all serotypes limits their application.
The evidence to support the recommendation and widespread use of the TT to aid the diag-
nosis of dengue fever is mixed with variable sensitivity and specificity being reported previ-
ously(15–21). The aim of this study is to map the evidence, assess the quality of the studies and
perform a diagnostic accuracy meta-analysis of the diagnosis of dengue using the TT compared
to ELISA.
Methods
Data Sources and Searches
The protocol for this systematic review was registered at PROSPERO (International prospec-
tive register of systemic reviews, http://www.crd.york.ac.uk/PROSPERO/display_record.asp?
ID=CRD42015020323). We searched Medical Literature databases Analysis and Retrieval Sys-
tem Online (Medline), Excerpta Medical Database (EMBASE), Allied and Complementary
Medicine Database (AMED), Global health, Biological Abstracts/Reports, Reviews, Meetings
(BIOSIS) altogether through OVID. Latin American and Caribbean Health Sciences (LILACS)
and the Cochrane Library through their website for relevant publications until April 2016.
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Additionally, we searched the WHO ICTRP (International Clinical Trials Registry Platform)
and ClinicalTrials.gov for completed and ongoing studies.
The search, performed according to the Cochrane Highly Sensitive Search Strategy, used the
following terms: “Rumpel-Leede” OR capillary OR “blood pressure cuff” OR petechiae OR tour-
niquet OR “Hess” AND dengue. The search was sensitive, we used no study filters and no lan-
guage or publication restrictions. We checked the reference lists of all primary studies included
for additional references. There were no language or publication restrictions on our search.
We included cross-sectional and cohort studies that evaluated the diagnostic accuracy of
tourniquet test for dengue infection. Both retrospective and prospective studies that consecu-
tively or randomly selected patients were included, together with studies that used delayed veri-
fication for gold standard. We included studies looking at patients presenting with fever who
were subsequently tested for dengue using both the TT (index test) and ELISA detection of
antibody response (reference standard).
For this review, definitions of dengue were used according to those proposed by the WHO
[11,12], as these were the definitions used during the time period from which studies were
drawn. For the purposes of this meta-analysis, ‘dengue’ was considered to consist of non-severe
‘dengue fever’ and ‘haemorrhagic dengue fever’, defined as follows. Dengue fever included
fever plus 2 or more symptoms of nausea/vomiting, rash, aches and pains. Dengue hemor-
rhagic fever (DHF) was considered as infection accompanied by haemorrhagic manifestations
such as petechiae and mucosal or gastro-intestinal bleeding[11,12].
Three comparisons were performed; TT vs. ELISA to diagnose dengue (i.e. both non-severe
dengue fever plus DHF; TT vs. ELISA to diagnose dengue fever and TT vs. ELISA to diagnose
DHF.
Study Selection
Two review authors (AJG, HR) independently assessed all studies identified from the database
searches by screening titles and abstracts using the Review Management website Covidence
(http://www.covidence.org). We separated potential studies for full-text reading. A third review
author (ET) resolved any disagreements, and reasons for including and excluding trials were
recorded.
Data Extraction and Quality Assessment
Two review authors (AJG, HR) independently extracted data from the included studies using a
standard data extraction form. With this form we extracted information of study design, partic-
ipant description, index test description, reference test description, dengue classification and
total number of participants. A 2x2 table was created for each study comparing both tests.
All included studies were assessed for their methodological quality using the quality assess-
ment tool for diagnostic accuracy studies (QUADAS-2)[23]. The tool is composed of 17 items
regarding study patient selection, index test, reference standard and flow and timing. For each
domain mentioned there are items for risk of bias and applicability. Items were scored as posi-
tive (low risk of bias), negative (high risk of bias), or insufficient information (unclear). A
description of each assessment was described in the results section.
Data Synthesis and Statistical Analysis
For each study, a 2x2 contingency table was constructed. We calculated sensitivity, specificity
and likelihood ratios (LRs). When the primary study had 0 in a cell of the 2x2 table, the value
of 1 was added, so calculations could be done[24], this only happened in one study(17). We
planned to exclude primary studies reporting two cells with 0, but this did not occur.
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The sensitivity, specificity and LRs were pooled from each study and a forest plot was gener-
ated with 95% confidence intervals. Due to the variability in diagnostic data, we logit-trans-
formed sensitivity and specificity for each primary study and for the aggregate result,
considering variability within-study and between-study. The output results are random effects
estimates of the mean sensitivity and specificity with corresponding 95% CI. The weighing con-
sidered the inverse of the standard error, so indirectly to the sample size reported in the studies.
Inconsistency (I2) was explored as an indicator of statistical heterogeneity[24]. Summary
receiver operating characteristic (ROC) curves were generated with calculation of area under
the curve (AUC) as an indicator of test accuracy. To assess for the possibility of publication
bias, we constructed funnel plots to visually assess for signs of asymmetry [25].
Statistical analyses were performed with Stata v10.0 (StataCorp LP, Texas, USA) and with
RevMan v5.3 (The Nordic Cochrane Centre, Copenhagen, Denmark)[26].
Results
We identified 1610 studies of which 637 were excluded as duplicates (Fig 1). A total of 973
studies were assessed on the basis of the title and abstract, of which 883 were excluded because
Fig 1. Flow chart of systematic review process.
doi:10.1371/journal.pntd.0004888.g001
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they did not fulfill inclusion criteria. Full text studies were retrieved for 90 titles, of which 74
were excluded (Table 1): unable to extract absolute numbers of true positives, false positives,
false negatives, and true negatives (n = 46), wrong test (n = 15) and wrong study designs
(n = 13)[4–8,27–95].
The remaining 16 studies were included in the systematic review and meta-analysis[13–
21,96–102] (Table 2), 14 of which were prospective cohorts while two were retrospective cohort
studies. The number of participants in each study ranged from 79 to 13,548. Ten studies were
from countries in Asia and six studies from Latin America.
All the analysis showed high levels of heterogeneity, represented by an I2 ranging from 75%
to 100%. Given this considerable heterogeneity between studies, we performed a random
effects meta-analysis presented below.
Methodological Quality of Included Studies
We used the instrument QUADAS-2, which is composed of four quality categories (patient
selection, reference standard, index test, and flow and timing), to critically appraise each
included study (Fig 2). Six studies (33%) were considered to have high risk of bias in patient
selection due to inclusion of patient data from a database, raising the possibility of bias from
multiple assessors, or selection of patients with pre-existing disease. Two studies (17%) had not
adequately described their sampling methods, so were classified as unclear risk. Eight studies
(50%) were low risk of bias for patient selection.
Considering the Reference standard category (ELISA), all studies were considered low risk
of bias. For the Index test category, four studies (25%) had not clearly described the process
used to conduct the TT, blind assessors or train assessors.
For the flow and timing category, only two studies (12.5%) were considered at high risk of
bias as the TT was repeated multiple times over a period of several days. Four studies (25%)
were considered unclear risk due to lack of information of withdrawals and appropriate
sequencing of tests.
Dengue vs ELISA
In this comparison, we included all 16 studies including both non-severe dengue fever and DHF
cases. The pooled sensitivity for dengue diagnosis was 0.58 (95% CI, 0.43–0.71) and the specific-
ity was 0.71 (95% CI, 0.60–0.80)(Fig 3). The positive predictive value was 1.63 (95% CI, 1.45–
1.82). The negative predictive value was 0.60 (95% CI, 0.51–0.71). The Diagnostic Odds Ratio
was 2.88 (95% CI, 2.17–3.83). The area under the curve was 0.70 (95% CI 0.66–0.74)(Fig 4A).
Dengue Fever vs ELISA
In this comparison, we included six studies. The pooled subgroup analysis sensitivity for den-
gue fever diagnosis was 0.66% (95% CI, 0.47–0.81) and the specificity was 0.68 (95% CI, 0.55–
0.80)(Fig 5). The positive predictive value was 1.81 (95% CI, 1.45–2.25). The negative predic-
tive value was 0.52 (95% CI, 0.36–0.75). The Diagnostic Odds Ratio was 3.80 (95% CI, 2.40–
6.00). The area under the curve was 0.73 (95% CI 0.68–0.76)(Fig 4B).
Dengue Haemorrhagic Fever vs ELISA
In this comparison, we included seven studies. In the pooled subgroup analysis, sensitivity
for dengue haemorrhagic fever diagnosis was 0.63 (95% CI, 0.39–0.82) and the specificity
was 0.60 (95% CI, 0.48–0.70). The positive predictive value was 1.54 (95% CI, 1.06–2.24)(Fig
6). The negative predictive value was 0.59 (95% confidence interval, 0.37–0.86). The
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Table 1. Excluded studies with reasons.
Study Reason for exclusion Study Reason for exclusion Study Reason for exclusion
Ahmed 2001[27] No data to be
extracted
Gregory 2010[96] No data to be
extracted
Muhammad 2006[7] No data to be
extracted
Arif 2009[28] No data to be
extracted
Guzman 1996[46] No data to be
extracted
Munir 1982[8] No data to be
extracted
Awasthi 2012[29] Wrong test Hanif 2011[47] No data to be
extracted
Munir 2014[60] No data to be
extracted
Ayyub 2006[30] No data to be
extracted
Horstick 2012[48] Wrong study design Namvongsa 2013[61] No data to be
extracted
Bandyopadhyay 2006
[31]
Wrong study design Horstick 2014[49] Wrong study design Narayanan 2003[62] No data to be
extracted
Cavalcanti 2010[32] Wrong test Ismail 2006[50] No data to be
extracted
Naskar 2014[63] Wrong test
Chairulfatah 1995[33] No data to be
extracted
Jhamb 2010[51] Wrong study design Nunes Araujo 2003[64] Wrong test
Chuansumrit 2010[34] No data to be
extracted
Kabra 1999[4] No data to be
extracted
Padbidri 1995[65] Wrong study design
Chutinimitkul 2005[35] Wrong test Kalayanarooj 2003
[52]
Wrong study design Pancharoen 2001[66] No data to be
extracted
Daniel 2005[36] No data to be
extracted
Kapse 2003[53] Wrong study design Pandey 2008[67] Wrong test
Diaz Quijano 2008[37] No data to be
extracted
Kittitrakul 2015[54] No data to be
extracted
Phuong 2006[68] No data to be
extracted
Diaz Quijano 2009[38] Wrong test Kulkarni 2010[55] No data to be
extracted
Prathyusha 2013[69] No data to be
extracted
Diaz Quijano 2010[39] No data to be
extracted
Mamani 2010[56] No data to be
extracted
Quiroz Moreno 2006[70] Wrong test
Eram 1979[40] No data to be
extracted
Manjith 2002[5] No data to be
extracted
Ramirez Ronda 1987[71] Wrong study design
Faridi 2008[41] No data to be
extracted
Meltzer 2012[57] Wrong test Ramirez Zepeda 2009
[72]
No data to be
extracted
Filho 2012[42] No data to be
extracted
Mendez 2003[6] No data to be
extracted
Rao 2013[73] No data to be
extracted
Fonseca 2012[43] Wrong test Mishra 2014[58] Wrong test Restrepo 2012[74] Wrong test
Gomber 2001[44] No data to be
extracted
Mourao 2007[59] No data to be
extracted
Ribeiro 2010[75] No data to be
extracted
Richards 1997[76] No data to be
extracted
Sri 1999[82] Wrong test Villar 2011[88] Wrong test
Rigau Perez 1997[77] No data to be
extracted
Sunil 2001[83] No data to be
extracted
Wali 1999[89] No data to be
extracted
Setiati 2007[78] No data to be
extracted
Tham 1996[84] Wrong study design Whitehorn 2010[90] Wrong study design
Shah 2006[79] No data to be
extracted
Tomashek 2010[85] No data to be
extracted
Yadav 2008[92] Wrong study design
Sharmin 2013[80] No data to be
extracted
Uddin 2014[86] No data to be
extracted
Yewale 2009[93] Wrong study design
Wiwanitkit 2005[91] Wrong test Zhang 2005[95] No data to be
extracted
Zhang 2007[94] No data to be
extracted
Shibani 2006[81] Wrong study design Vargas 2001[87] No data to be
extracted
doi:10.1371/journal.pntd.0004888.t001
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Diagnostic Odds Ratio was 2.08 (95% CI, 1.15–6.82). The area under the curve was 0.66
(95% CI, 0.62–0.70)(Fig 4C).
Dengue Shock Syndrome
None of the included studies reported data comparing TT and ELISA for patients with dengue
shock syndrome.
Subgroup Analysis for Dengue vs ELISA
We conducted a subgroup analysis for the included studies considering only children and ado-
lescents aged 6 months to 15 years. No analysis with adults were conducted, since all 16
Fig 2. Quality Assessment of Diagnostic Accuracy Studies II.
doi:10.1371/journal.pntd.0004888.g002
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Fig 3. Forest plot for individual studies and pooled sensitivity and specificity for Dengue x ELISA.Q: chi-squared statistic; df: degrees of freedom; I2:
inconsistency of studies’ results; Dashed line means the mean number found across studies.
doi:10.1371/journal.pntd.0004888.g003
Fig 4. RoC curve for all three comparisons conducted in the study. A = Dengue x ELISA; B = Dengue fever x ELISA, C = Dengue haemorrhagic fever x
ELISA.
doi:10.1371/journal.pntd.0004888.g004
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included studies did not explore only adults’ participants, when they analyzed adults they
mixed the data with children and adolescents
In this subgroup analysis, we included eight studies including both non-severe dengue fever
and DHF cases. The pooled sensitivity for dengue diagnosis was 0.71 (95% CI, 0.59–0.82) and
the specificity was 0.59 (95% CI, 0.47–0.70) (Fig 7). The positive predictive value was 1.66 (95%
CI, 1.45–1.91). The negative predictive value was 0.52 (95% CI, 0.43–0.64). The Diagnostic Odds
Ratio was 3.44 (95% CI, 2.25–5.25). The area under the curve was 0.69 (95% CI, 0.65–0.73).
Sensitivity Analysis
We conducted the following sensitivity analyses of the Dengue vs ELISA analysis: 1. In order to
analysis the impact of the mix of cut-off points reported by studies (10 petechiae per one
square inch and20 petechiae per one square inch) we repeated the analysis in just studies
Fig 5. Forest plot for individual studies and pooled sensitivity and specificity for Dengue Fever x ELISA.Q: chi-squared statistic; df: degrees of
freedom; I2: inconsistency of studies’ results; Dashed line means the mean number found across studies.
doi:10.1371/journal.pntd.0004888.g005
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using the criteria of20 petechiae per one square inch. 2. We conducted another sensitivity
analysis removing all studies with high risk of selection bias.
Thus, we included 12 studies including both non-severe dengue fever and DHF cases. The
pooled sensitivity for dengue diagnosis was 0.64 (95% CI, 0.51–0.74) and the specificity was
0.68 (95% CI, 0.55–0.80) (Fig 8). The positive predictive value was 1.68 (95% CI, 1.46–1.93).
The negative predictive value was 0.56 (95% CI, 0.47–0.66). The Diagnostic Odds Ratio was
3.37 (95% CI, 2.33–4.86). The area under the curve was 0.71 (95% CI, 0.67–0.75).
We removed six studies with high risk for selection bias. Thus, 10 studies including both
non-severe dengue fever and DHF cases were combined. The pooled sensitivity for dengue
diagnosis was 0.64 (95% CI, 0.50–0.76) and the specificity was 0.66 (95% CI, 0.56–0.75) (Fig 9).
The positive predictive value was 1.74 (95% CI, 1.52–1.98). The negative predictive value was
0.57 (95% CI, 0.48–0.69). The Diagnostic Odds Ratio was 3.37 (95% CI, 2.35–4.85). The area
under the curve was 0.70 (95% CI, 0.66–0.74).
Fig 6. Forest plot for individual studies and pooled sensitivity and specificity for Dengue Haemorragic Fever x ELISA.Q: chi-squared statistic; df:
degrees of freedom; I2: inconsistency of studies’ results; Dashed line means the mean number found across studies.
doi:10.1371/journal.pntd.0004888.g006
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Investigations of Publication Bias and Heterogeneity
Funnel plot asymmetry test revealed evidence of publication bias (Fig 10). The I2 statistics
were, as expected in diagnostic meta-analyses, over 95% in all three comparisons made (Figs 3,
5 and 6)[26].
Discussion
Dengue fever is an infection with significant global public health importance. Increasing
urbanization and crowding in endemic areas, coupled with failing vector control programs
have resulted in a significant increase in cases and major outbreaks since the 1950’s[11]. This is
the first systematic review and meta-analysis to specifically investigate and compare the utility
of the tourniquet test to diagnose dengue infection compared to the widely-used standard labo-
ratory ELISA testing.
Overall, our results demonstrate that the TT is a relatively poor diagnostic test for dengue of
any severity. When assessed by ROC analysis, low AUCs (0.70) suggest that the TT, as an
Fig 7. Forest plot for individual studies and pooled sensitivity and specificity for Dengue x ELISA in children and adolescents aged from 6months
to 15 years.Q: chi-squared statistic; df: degrees of freedom; I2: inconsistency of studies’ results; Dashed line means the mean number found across studies.
doi:10.1371/journal.pntd.0004888.g007
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isolated diagnostic test and in comparison to ELISA, should be classified as a “relatively poor”
test.[103]
Funnel plot analysis suggests that there may be a major element of publication bias in the
previous reporting of tourniquet test usefulness. Many studies were observed to have overly
extreme results, i.e. have a large effect for positive TT and large effect against TT. Reasons for
this may include small sample size with wide standard errors, or other problems in study
design, with resulting overemphasis in reporting positive or confirmatory results. Resulting
estimates of TT efficacy may there have demonstrated a significant skew towards overly posi-
tive effects.
In our subgroups analysis, we removed the studies that mixed adults and kept only children
and adolescents from 6 months to 15 years of age. We did not find any significant change in
utility of TT in diagnosing dengue infection. We did further sensitivity analyses considering
both a diagnostic cut-off of20 petechiae per one square inch and a repeat analysis after
removing studies at high risk of bias for patient selection. Neither of these analyses led to any
Fig 8. Forest plot for individual studies and pooled sensitivity and specificity for Dengue x ELISA cut-off points reported20 petechiae per one
square inch.Q: chi-squared statistic; df: degrees of freedom; I2: inconsistency of studies’ results; Dashed line means the mean number found across
studies.
doi:10.1371/journal.pntd.0004888.g008
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significant difference in our findings. This is of interest, as using a higher, stricter cutoff would
generally reduce sensitivity but increase specificity for diagnosis. Lack of an effect seen when
increasing the threshold to20 petechiae here, suggests limited biological correlation of this
clinical observation. Additional analyses demonstrated that data from individual studies were
scattered and included a wide range of participant age-groups and geographic regions. Ideally,
we would also have liked to investigate the performance of the TT in different age-groups
using a range of cutoff thresholds, for example,10 petechiae in children,20 petechiae in
adults. It was not possible to extract these age-group specific data from many of the primary
studies however.
Considering the subgroup analysis, we could hypothesize that increasing the threshold for
diagnosing dengue the sensitivity would decrease and specificity increase, however this hypoth-
esis was not confirmed, the lack effect on the outcomes shows the need to use a more rigorous
test to diagnose dengue.
Using the GRADE approach to assess the quality of the evidence generated in this study, we
can classify it as low, which means that “further research is very likely to have an important
Fig 9. Forest plot for individual studies and pooled sensitivity and specificity for Dengue x ELISA removing six studies with high risk for selection
bias.Q: chi-squared statistic; df: degrees of freedom; I2: inconsistency of studies’ results; Dashed line means the mean number found across studies.
doi:10.1371/journal.pntd.0004888.g009
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impact on our confidence in the estimate of effect and is likely to change the estimate or any esti-
mate of effect is very uncertain”, the evidence was downgraded due to imprecision (wide confi-
dence intervals) and inconsistency (widely different estimates) across the included studies.
Further limitations to our analysis of data currently available in the literature may arise
from heterogeneity in the time periods at which the tests were performed, or the number of
occasions on which the test was repeated prior to getting a positive result. Additional practical
reasons for previous overestimation of the efficacy of the TT may include difficulties in inter-
preting a positive result in individuals with different skin pigmentation or variation in the viru-
lence or pathogenicity of strains resulting in higher rates of capillary permeability, for example
in South East Asian genotypes of the DEN-2/3 serotypes.
Here, we have assessed and presented the best available evidence for use of the TT in making
a diagnosis of dengue infection. Clearly the TT should not be used in isolation for making a
diagnosis of dengue, however given the evidence available it is doubtful as to whether the test
offers any additional benefit over and above careful clinical evaluation. Inconsistencies in data
reporting in the primary study datasets also render assessment of whether the TT maybe useful
for particular population/disease subgroups currently infeasible.
Conclusions
The clinical diagnosis of dengue is challenging as disease presentation is almost indistinguish-
able to many other infections commonly found in the tropics[104]. Current WHO recommen-
dations suggest a combination of clinical history, leukopenia and the tourniquet test result to
make a diagnosis if ELISA testing is not available or prior to the availability of results. Given
the requirement for paired sera samples in many areas where dengue is endemic to demon-
strate an increase in antibody titre, reliance on clinical diagnosis will be still greater.
Fig 10. Publication bias presentation using funnel plot for Dengue x ELISA.
doi:10.1371/journal.pntd.0004888.g010
Tourniquet Test and Dengue Diagnosis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004888 August 3, 2016 18 / 23
While still widely used, our analyses suggest that data supporting routine use of the tourni-
quet test is, at best, relatively poor, however it is important to consider that the quality of the evi-
dence is low due to imprecision and inconsistency across the included studies. Furthermore, the
data used to underpin current international recommendations likely overestimate its utility.
Over reliance on the use of the TT to support a clinical diagnosis of dengue infection may result
in misdiagnosis of patients and inaccurate estimates of disease incidence; relatively low sensitiv-
ity but higher specificity suggest that disease incidence may be underestimated if the TT is overly
relied on. While current recommendations should be re-examined in light of these findings,
replacement of the tourniquet test in routine clinical practice will only come once improved
point-of-care diagnostics are made more widely available, especially in resource-poor areas.
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